全身麻醉与非全身麻醉下取栓术结局:EXTEND-IA试验与SELECT研究的汇总患者水平分析
该汇总患者水平分析纳入EXTEND-IA、EXTEND-IA TNK、EXTEND-IA TNK part II和SELECT研究中725例接受血管内取栓的患者,经倾向评分匹配后比较全身麻醉与非全身麻醉的功能结局。匹配的182对患者中,全身麻醉与更差功能结局独立相关(adj. cOR 0.64,95%CI 0.44-0.93,p=0.021),且侧支循环不良者全身麻醉结局更差,作者指出适应证混杂可能仍存在。
要点
- 匹配后全身麻醉与更差功能结局独立相关(adj. cOR 0.64,95%CI 0.44-0.93,p=0.021)。
- 全身麻醉组神经功能恶化比例14.9% vs 非全身麻醉组8.9%(aOR 2.10,95%CI 1.02-4.33,p=0.045)。
- 侧支循环不良者全身麻醉功能结局更差(adj. cOR 0.47,95%CI 0.29-0.76,p=0.002),侧支良好者无差异。
核心结论
- 在3项随机试验和1项前瞻性队列研究的汇总患者水平队列中,倾向评分匹配分析显示全身麻醉与取栓后更差功能结局相关,尤其在侧支循环不良的患者中。
- 作者指出尽管分析具有双重稳健性,适应证混杂可能仍存在;这些发现对全身麻醉与非全身麻醉的随机试验有意义,并可能有助于临床医生选择麻醉方式。
- 本研究提供III级证据表明全身麻醉与取栓患者更差功能结局相关。
研究设计与样本
- 汇总患者水平分析,纳入EXTEND-IA、EXTEND-IA TNK、EXTEND-IA TNK part II和SELECT研究。
- 共725例接受血管内取栓的患者,其中299例(41%)接受全身麻醉,426例(59%)接受非全身麻醉。
- 采用倾向评分匹配样本比较全身麻醉与非全身麻醉的功能结局(改良Rankin量表评分分布)。
- 评估灌注影像侧支循环(以低灌注强度比HIR评估:Tmax>10秒/Tmax>6秒,良好侧支为HIR<0.4,不良侧支为HIR≥0.4)对麻醉类型与取栓结局关联的影响。
主要发现
- 基线特征在就诊时美国国立卫生研究院卒中量表评分(全身麻醉中位数18[四分位距13-22] vs 非全身麻醉16[11-20],p<0.001)和缺血核心体积(全身麻醉15.0 mL[3.2-38.0] vs 非全身麻醉9.0 mL[0.0-31.0],p<0.001)方面存在差异。
- 全身麻醉与更长最后已知良好到动脉穿刺时间相关(203分钟[157-267] vs 186分钟[138-252],p=0.002),但手术时间相似(35.5分钟[23-59] vs 34分钟[22-54],p=0.51)。
- 在182对倾向评分匹配患者中,基线特征相似;全身麻醉与更差功能结局独立相关(adj. cOR 0.64,95%CI 0.44-0.93,p=0.021),并与更高神经功能恶化相关(全身麻醉14.9% vs 非全身麻醉8.9%,aOR 2.10,95%CI 1.02-4.33,p=0.045)。
- 侧支循环不良患者接受全身麻醉时功能结局更差(adj. cOR 0.47,95%CI 0.29-0.76,p=0.002),而侧支循环良好者无差异(adj. cOR 0.93,95%CI 0.50-1.74,p=0.82),交互作用p=0.07。
- 总体及侧支循环良好患者中梗死体积增长无差异,而侧支循环不良患者接受全身麻醉时梗死体积增长更大,侧支循环与麻醉类型对梗死体积增长率的交互作用显著(交互作用p=0.020)。
关键数值与推荐
- 功能结局以改良Rankin量表评分分布比较,采用调整共同比值比(adj. cOR)及95%CI。
- 侧支循环良好定义为HIR<0.4,不良定义为HIR≥0.4(HIR=Tmax>10秒/Tmax>6秒)。
- 证据等级:本研究提供III级证据。
临床怎么用
- 作者认为这些发现可能有助于临床医生选择麻醉方式。
- 原文未据此给出具体推荐。
局限性
- 作者指出尽管分析具有双重稳健性,适应证混杂可能仍存在。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: The effect of anesthesia choice on endovascular thrombectomy (EVT) outcomes is unclear. Collateral status on perfusion imaging may help identify the optimal anesthesia choice. METHODS: In a pooled patient-level analysis of EXTEND-IA, EXTEND-IA TNK, EXTEND-IA TNK part II, and SELECT, EVT functional outcomes (modified Rankin Scale score distribution) were compared between general anesthesia (GA) vs non-GA in a propensity-matched sample. Furthermore, we evaluated the association of collateral flow on perfusion imaging, assessed by hypoperfusion intensity ratio (HIR) - Tmax > 10 seconds/Tmax > 6 seconds (good collaterals - HIR < 0.4, poor collaterals - HIR ≥ 0.4) on the association between anesthesia type and EVT outcomes. RESULTS: Of 725 treated with EVT, 299 (41%) received GA and 426 (59%) non-GA. The baseline characteristics differed in presentation National Institutes of Health Stroke Scale score (median [interquartile range] GA: 18 [13-22], non-GA: 16 [11-20], p < 0.001) and ischemic core volume (GA: 15.0 mL [3.2-38.0] vs non-GA: 9.0 mL [0.0-31.0], p < 0.001). In addition, GA was associated with longer last known well to arterial access (203 minutes [157-267] vs 186 minutes [138-252], p = 0.002), but similar procedural time (35.5 minutes [23-59] vs 34 minutes [22-54], p = 0.51). Of 182 matched pairs using propensity scores, baseline characteristics were similar. In the propensity score-matched pairs, GA was independently associated with worse functional outcomes (adjusted common odds ratio [adj. cOR]: 0.64, 95% CI: 0.44-0.93, p = 0.021) and higher neurologic worsening (GA: 14.9% vs non-GA: 8.9%, aOR: 2.10, 95% CI: 1.02-4.33, p = 0.045). Patients with poor collaterals had worse functional outcomes with GA (adj. cOR: 0.47, 95% CI: 0.29-0.76, p = 0.002), whereas no difference was observed in those with good collaterals (adj. cOR: 0.93, 95% CI: 0.50-1.74, p = 0.82), p interaction: 0.07. No difference was observed in infarct growth overall and in patients with good collaterals, whereas patients with poor collaterals demonstrated larger infarct growth with GA with a significant interaction between collaterals and anesthesia type on infarct growth rate (p interaction: 0.020). DISCUSSION: GA was associated with worse functional outcomes after EVT, particularly in patients with poor collaterals in a propensity score-matched analysis from a pooled patient-level cohort from 3 randomized trials and 1 prospective cohort study. The confounding by indication may persist despite the doubly robust nature of the analysis. These findings have implications for randomized trials of GA vs non-GA and may be of utility for clinicians when making anesthesia type choice. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that use of GA is associated with worse functional outcome in patients undergoing EVT. TRIAL REGISTRATION INFORMATION: EXTEND-IA: ClinicalTrials.gov (NCT01492725); EXTEND-IA TNK: ClinicalTrials.gov (NCT02388061); EXTEND-IA TNK part II: ClinicalTrials.gov (NCT03340493); and SELECT: ClinicalTrials.gov (NCT02446587).
引用
- Sarraj A, Albers GW, Mitchell PJ, et al. Thrombectomy Outcomes With General vs Nongeneral Anesthesia: A Pooled Patient-Level Analysis From the EXTEND-IA Trials and SELECT Study. Neurology. 2022. PMID: 36289001. doi:10.1212/WNL.0000000000201384
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。